Clinical Cancer Drugs
Title:Book Review: Handbook of Melanoma Edited by Jonathan S. Zager, Vernon K. Sondak, and Ragini Kudchadkar
Volume: 4
Author(s): Feng Liang
Affiliation:
Export Options
About this article
Cite this article as:
Liang Feng , Book Review: Handbook of Melanoma Edited by Jonathan S. Zager, Vernon K. Sondak, and Ragini Kudchadkar, Clinical Cancer Drugs 2017; 4 (2) . https://dx.doi.org/10.2174/2212697X0402180109171607
DOI https://dx.doi.org/10.2174/2212697X0402180109171607 |
Print ISSN 2212-697X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-6988 |
20
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
CD44 and EpCAM: Cancer-Initiating Cell Markers
Current Molecular Medicine Current Status of Therapeutic _targeting of Developmental Signalling Pathways in Oncology
Current Pharmaceutical Biotechnology Steroid Receptor-Associated Immunophilins: Candidates for Diverse Drug-_targeting Approaches in Disease
Current Molecular Pharmacology _targeted Delivery of Bleomycin: A Comprehensive Anticancer Review
Current Cancer Drug _targets Breast Infrared Thermography Segmentation Based on Adaptive Tuning of a Fully Convolutional Network
Current Medical Imaging Progress on the Biological Activities of Helicid and its Derivatives
Current Organic Chemistry Recent Advances on Liquid Chromatographic and Mass Spectrometric Analysis of Selective Estrogen Receptor Modulators (SERMs) in Biological Fluids
Current Chromatography Multiple Protective Functions of Sigma1 Receptor
Current Protein & Peptide Science Plumbagin: A Potential Anti-cancer Compound
Mini-Reviews in Medicinal Chemistry Data-driven Approach to Detect and Predict Adverse Drug Reactions
Current Pharmaceutical Design New Improved Drug Delivery Technologies for Pentacyclic Triterpenes: A Review
Protein & Peptide Letters _targeted Delivery of Natural Bioactives and Lipid-nanocargos against Signaling Pathways Involved in Skin Cancer
Current Medicinal Chemistry Chitosan Nanoparticles for Melanoma Cancer Treatment by Photodynamic Therapy and Electrochemotherapy Using Aminolevulinic Acid Derivatives
Current Medicinal Chemistry Regulating miRNAs Expression by Resveratrol: Novel Insights based on Molecular Mechanism and Strategies for Cancer Therapy
Current Molecular Pharmacology Expression of mTOR/70S6K Signaling Pathway in Melanoma Cancer Cells and the Effects of Dacarbazine and Metformin
Current Cancer Therapy Reviews Angiotensin-converting Enzyme Inhibitors and Angiotensin Receptor Blockers as Potential Therapeutic Options for Pancreatic Cancer
Current Cancer Drug _targets A Common Biological Mechanism in Cancer and Alzheimers Disease?
Current Alzheimer Research Curcumin Inhibits Vasculogenic Mimicry <i>via</i> Regulating ETS-1 in Renal Cell Carcinoma
Current Cancer Drug _targets Inhibitors of Apoptosis Proteins (IAPs) as Potential Molecular _targets for Therapy of Hematological Malignancies
Current Molecular Medicine Epigenetic Control of MicroRNA Expression and Aging
Current Genomics